A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ravi Thadhani, MD
Massachusetts General Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Tucson, Arizona, United States
- Facility name not stated
Washington D.C., District of Columbia, United States
- Facility name not stated
Evanston, Illinois, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Las Vegas, Nevada, United States
- Facility name not stated
Great Neck, New York, United States
- Facility name not stated
Ridgewood, New York, United States
- Facility name not stated
Charlotte, North Carolina, United States
- Facility name not stated
Cincinnati, Ohio, United States
- Facility name not stated
Nashville, Tennessee, United States
- Facility name not stated
Fort Worth, Texas, United States
- Facility name not stated
Grand Prairie, Texas, United States
- Facility name not stated
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2013
- Primary completion
- 31 May 2014
- Completion
- 30 Jun 2014
- Last update posted
- 18 Aug 2017
- Registered enrollment
- 62
- Registry id
- NCT01922843
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.